Literature DB >> 1582599

Control of muscle tone in the human colon.

C J Steadman1, S F Phillips, M Camilleri, N J Talley, A Haddad, R Hanson.   

Abstract

Human colonic muscle tone varies diurnally and postprandially in predictable ways. Increased tone reduces the capacity of the colon to store contents after a meal, whereas increased distensibility (lesser tone) during sleep enlarges the storage capabilities and may slow transit. We tested the hypothesis that antidiarrhoeal drugs would also alter tone which, in turn, might reduce diarrhoea by facilitating the storage and salvage of fluids. Using a colonic barostat to create low pressure, isobaric colonic distension in healthy volunteers, we found that intravenous atropine (0.01 mg/kg) relaxed the colon during fasting, reduced the postprandial increase in tone, and enhanced relaxation in the late (1-2 hour) postprandial period. Intravenous morphine (0.1 mg/kg) caused variable effects soon after injection but, in fasting subjects, the descending colon relaxed 70-90 minutes after morphine. These changes in colonic motility were not always obvious by conventional manometric recording. Colonic distensibility is increased by antidiarrhoeal drugs and this effect may contribute to their efficacy in slowing colonic transit and augmenting absorption.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1582599      PMCID: PMC1374074          DOI: 10.1136/gut.33.4.541

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  18 in total

1.  The intraluminal pressure patterns in diverticulosis of the colon: Part II The effect of morphine.

Authors: 
Journal:  Gut       Date:  1964-06       Impact factor: 23.059

2.  Gastric tone measured by an electronic barostat in health and postsurgical gastroparesis.

Authors:  F Azpiroz; J R Malagelada
Journal:  Gastroenterology       Date:  1987-04       Impact factor: 22.682

3.  Capacity of the human colon to absorb fluid.

Authors:  J C Debongnie; S F Phillips
Journal:  Gastroenterology       Date:  1978-04       Impact factor: 22.682

4.  Variation of muscle tone in the human colon.

Authors:  C J Steadman; S F Phillips; M Camilleri; A C Haddad; R B Hanson
Journal:  Gastroenterology       Date:  1991-08       Impact factor: 22.682

5.  Participation of gastric mechanoreceptors and intestinal chemoreceptors in the gastrocolonic response.

Authors:  J Wiley; D Tatum; R Keinath; O Y Chung
Journal:  Gastroenterology       Date:  1988-05       Impact factor: 22.682

6.  Measurement of tone in canine colon.

Authors:  M Neri; S F Phillips; A Fich
Journal:  Am J Physiol       Date:  1991-03

7.  Physiological variations in canine gastric tone measured by an electronic barostat.

Authors:  F Azpiroz; J R Malagelada
Journal:  Am J Physiol       Date:  1985-02

8.  Sensitivities of human jejunum, ileum, proximal colon, and gallbladder to cholecystokinin octapeptide.

Authors:  J E Kellow; L J Miller; S F Phillips; A C Haddad; A R Zinsmeister; J W Charboneau
Journal:  Am J Physiol       Date:  1987-03

9.  Role of opiate receptors in the regulation of colonic transit.

Authors:  P N Kaufman; B Krevsky; L S Malmud; A H Maurer; M B Somers; J A Siegel; R S Fisher
Journal:  Gastroenterology       Date:  1988-06       Impact factor: 22.682

10.  Morphine attenuates cholinergic nerve activity in human isolated colonic muscle.

Authors:  D E Burleigh; S J Trout
Journal:  Br J Pharmacol       Date:  1986-06       Impact factor: 8.739

View more
  25 in total

1.  Meal induced rectosigmoid tone modification: a low caloric meal accurately separates functional and organic gastrointestinal disease patients.

Authors:  M Di Stefano; E Miceli; A Missanelli; S Mazzocchi; G R Corazza
Journal:  Gut       Date:  2006-01-24       Impact factor: 23.059

2.  Pretreatment with diphenoxylate hydrochloride/atropine sulfate (Lomotil) does not decrease physiologic bowel FDG activity on PET/CT scans of the abdomen and pelvis.

Authors:  Robert Murphy; Kirk M Doerger; Mark A Nathan; Val J Lowe
Journal:  Mol Imaging Biol       Date:  2008-11-27       Impact factor: 3.488

3.  Lack of an Effect of Gastric Capsaicin on the Rectal Component of the Gastrocolonic Response.

Authors:  Martina Führer; Johann Hammer
Journal:  Dig Dis Sci       Date:  2017-10-30       Impact factor: 3.199

4.  Effects of naloxegol on whole gut transit in opioid-naïve healthy subjects receiving codeine: A randomized, controlled trial.

Authors:  H Halawi; P Vijayvargiya; I Busciglio; I Oduyebo; D Khemani; M Ryks; D Rhoten; D Burton; L A Szarka; A Acosta; M Camilleri
Journal:  Neurogastroenterol Motil       Date:  2018-02-06       Impact factor: 3.598

Review 5.  Challenges to the therapeutic pipeline for irritable bowel syndrome: end points and regulatory hurdles.

Authors:  Michael Camilleri; Lin Chang
Journal:  Gastroenterology       Date:  2008-10-09       Impact factor: 22.682

6.  Standardization of barostat procedures for testing smooth muscle tone and sensory thresholds in the gastrointestinal tract. The Working Team of Glaxo-Wellcome Research, UK.

Authors:  W E Whitehead; M Delvaux
Journal:  Dig Dis Sci       Date:  1997-02       Impact factor: 3.199

7.  Effect of bisacodyl on postoperative bowel motility in elective colorectal surgery: a prospective, randomized trial.

Authors:  U Zingg; D Miskovic; I Pasternak; P Meyer; C T Hamel; U Metzger
Journal:  Int J Colorectal Dis       Date:  2008-07-30       Impact factor: 2.571

8.  Octreotide increases thresholds of colonic visceral perception in IBS patients without modifying muscle tone.

Authors:  M Bradette; M Delvaux; G Staumont; J Fioramonti; L Bueno; J Frexinos
Journal:  Dig Dis Sci       Date:  1994-06       Impact factor: 3.199

9.  Pouchitis: result of microbial imbalance?

Authors:  J G Ruseler-van Embden; W R Schouten; L M van Lieshout
Journal:  Gut       Date:  1994-05       Impact factor: 23.059

10.  Serotonergic mediation of postprandial colonic tonic and phasic responses in humans.

Authors:  M R von der Ohe; R B Hanson; M Camilleri
Journal:  Gut       Date:  1994-04       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.